abstract |
Antibodies capable of binding to thymic matrix lymphopoietin and uses thereof are disclosed. Anti-TSLP antibodies, or pharmaceutically acceptable salts or solvates thereof, including murine, chimeric and humanized antibodies of the light and heavy chain variable regions of anti-TSLP antibodies and antigen-binding fragments thereof, and medicaments for treating asthma Disclosed is its use as a drug, in particular its use in the manufacture of a medicament for treating a TSLP positive disease or condition. |